|Dr. Sam D Shemie||
Dr. Shemie’s area of specialty is organ replacement in critical illness. He is pediatric critical care physician and director of Extracorporeal Life Support program at the Montreal Children’s Hospital, McGill University. His recent research interests have included the clinical and policy impact of organ failure support technologies and the development and implementation of national ICU based organ donation strategies. He is the former chair of the Donation Committee of the Canadian Council for Donation and Transplantation.
|Dr. Constantine...||Dr. Constantine (Dean) Karvellas is an Assistant Professor of Medicine (Critical Care and Hepatology) at the University of Alberta. He has been an attending intensivist in the E. Garner King General Systems Intensive Care Unit since 2009. He is also involved with the Liver Transplant program as a Hepatologist. Dr Karvellas completed his medical degree at the University of Alberta in 2001. He went on to pursue training in Internal Medicine, Gastroenterology and Critical Care Medicine at the University of Alberta. In 2006, he completed training in hepatic failure at the Institute of Liver Studies, King's College Hospital in London, UK under Dr. Julia Wendon. In 2011, he completed master’s training in epidemiology through the Harvard School of Public Health. Dr. Karvellas’ publications reflect his interests in acute liver failure, acute on chronic liver failure, liver transplantation and extracorporeal liver support.|
|Dr. Robert MacLaren||Robert MacLaren, Pharm.D. is a professor in the Department of Clinical Pharmacy at the University of Colorado, clinical pharmacist in the medical ICU at the University of Colorado Hospital, and co-director of the critical care pharmacy residency and fellowship programs. Dr. MacLaren completed his undergraduate degree in pharmacy at the University of British Columbia, earned his Pharm.D. degree at the University of Utah, completed a critical care specialty residency at the University of Tennessee / Baptist Memorial Hospital, and recently received his MPH degree at the University of Colorado with a focus on policy. He worked for several years as a critical care specialist at the Queen Elizabeth II Health Sciences Centre in Halifax, Canada before joining the faculty at the University of Colorado in 1999. Dr. MacLaren has over eighty peer reviewed publications relating to the pharmacologic and nutritional therapies of critically ill patients and has secured over $750,000 in grant funding to support various research initiatives. His primary research foci surround gastrointestinal disturbances of the critically ill, optimizing patient comfort in the ICU, and demonstrating the value of clinical pharmacy services. He has been an invited speaker at national and international meetings. He is a fellow of the American College of Clinical Pharmacy and the Society of Critical Care Medicine and has served both organizations as chair or member of several committees.|
|Dr. James Downar||
James Downar is a Critical Care and Palliative Care Physician at the University Health Network in Toronto. He graduated from McGill Medical School and completed residency training in Internal Medicine, Critical Care and Palliative Care at the University of Toronto. He has a Master’s degree in Bioethics from the Joint Centre for Bioethics at the University of Toronto. He is the current chair of the Postgraduate Education Committee of the Canadian Society of Palliative Care Physicians, and the co-Chair of the Advisory Council of Physicians for Dying with Dignity, a Non-Profit Organization advocating for the legalization of Assisted Death in Canada. His research interests include communication and decision-making for seriously ill patients and their families; Palliative Care for the Critically Ill; and Palliative Care for Noncancer Illnesses
|Dr. Pierre Noel||
Dr. Pierre Noel is a Professor of Medicine in the Mayo Clinic College of Medicine and serves as the Director of the Blood and Marrow Transplant Program in the Division of Hematology at Mayo. He joined Mayo in 1988 and left in 2000 to serve as the Chief of Hematology and a Senior Clinician for the National Institute of Health Clinical Center in Bethesda and a Consultant for the United States Homeland and National Security Council in Washington, DC. He rejoined Mayo in 2010 and has held a joint appointment in the Department of Laboratory Medicine/Pathology and the Division of Hematology since that time.
Dr. Noel received his M.D. degree and completed an internal medicine residency at the University of Sherbrook in Montreal, Canada. He completed a fellowship in hematology and was a foundation scholar at the Mayo Clinic College of Medicine in Rochester, Minnesota. Dr. Noel served as an officer in the military special operations community from 1997 through 2010 and is currently an advisor to the federal government on issues pertaining to medical support to counterterrorism operations.
Dr. Noel is the Chair of the Scientific Committee for the Board of Directors at Blood Systems; is a member of the Mayo Clinic Board of Governors Government Relations Committee; is the Vice Chair of Research for the Division of Hematology/Oncology; and is the Chair of the Military Medicine Initiative at Mayo Clinic in Arizona.
Dr. Noel developed the myeloid research core at the NIH Warren Magnuson Clinical Center Department of Medicine. The focus of the laboratory was eosinophil and mast cell disorders. He has 62 peer reviewed articles, 16 book chapters and 52 published abstracts related to his fields of interest.
|Dr Julia Wendon||
Appointed as Consultant Physician at King's College Hospital in 1992. She was the lead clinician for the Liver Intensive Care Unit until 2007 and has developed a unique facility with a worldwide reputation for the care of critically ill patients with liver disease. She is currently Clinical Director of the Critical Care Division.
|Nadine Foster||Nadine spent a month in the ICU and over a year recovering. Chris and Nadine would like to share their story of recovery and some of the challenges they faced. They would also like to share their thoughts on continuity of care between ICU, the unit that receives the patient from the ICU, and on into the community. Long term outcomes of discharged ICU patients and their families might be greatly improved with this kind of follow up and support.|
Marcel received his undergraduate degree in Liberal Arts from Providence College in Providence, Rhode Island, and his graduate degree in theology and pastoral care from the Gregorian University and the North American College in Rome, Italy. He served in parish ministry for ten years before beginning work his in vocations and becoming rector of the college seminary program. He began working for Donor Network of Arizona in 1998 establishing their Donor Family aftercare program. Presently, he serves as the Director of Donor Family and Advocate Services guiding the Donation and Family Advocates in donation conversations. The present focus of his work and study is decision making and meaningful conversation with families in times of emotional crisis and trauma. Marcel has lectured across the United States to over 30 Organ Procurement Organizations about best practices in communication and donation conversations. In 2012 he was awarded the Musculoskeletal Transplant Foundation’s award for Donor Care for his work in donation with donor families.
|Dr Wes Ely||Dr. E. Wesley Ely, MD, MPH is a professor of medicine at Vanderbilt University School of Medicine with subspecialty training in Pulmonary and Critical Care Medicine and a particular passion for care of older critically ill patients. He is the Associate Director of Aging Research for the VA Tennessee Valley Geriatric Research and Education Clinical Center (GRECC). His research has focused on improving the care and outcomes of critically ill patients with sepsis and respiratory failure, with special emphasis on the problems facing older patients in the ICU (e.g., weaning from mechanical ventilation, delirium and cognitive impairment in the ICU, neuropsychological deficits post ICU care, and quality of death in the ICU). Dr. Ely has over 250 peer reviewed articles. As the founder of the Vanderbilt ICU Delirium and Cognitive Impairment Study Group, he currently serves as the principal investigator for the Coordinating Center's ongoing clinical trials in sedation and delirium and post-ICU cognitive impairment. Dr. Ely designs and leads a team of investigators in conducting both large cohort studies and randomized controlled clinical trials seeking both better understanding and management of critically ill patients in the ICU. Among other studies, Dr. Ely has been the principal investigator of two large NIH and VA-sponsored cohort investigations in ICU patients, with a focus on delirium and sedative/analgesic drug exposure and acquired cognitive and functional impairment in survivors of critical illness as well as the MIND-USA randomized controlled trial of antipsychotics versus placebo for ICU Delirium, an 18 center NIH-sponsored, Phase III investigation. He is especially thankful to have the privilege of working with such a talented and inter-disciplinary team of professionals from dozens of different training backgrounds to conduct this research in such an important public health domain. Importantly, he is married to Dr. Kim Ely, a surgical pathologist at Vanderbilt (herself a graduate of The Massachusetts Institute of Technology and Tulane University School of Medicine and also a member of AOA), with whom he has 3 lovely daughters who are together the pride of his life.|
|Dr. Robert Fowler||Rob Fowler is critical care physician and Associate Professor of Medicine at the University of Toronto and director of research for the Department Medicine at Sunnybrook Health Sciences Centre, Canada’s busiest trauma-critical care hospital. He received his medical degree at McGill University, his residency training at the University of Toronto, and completed a critical care fellowship and clinical epidemiology training at Stanford University. He is a past Clinician-Scientist of the Ontario Ministry of Health and Long-term Care and a current Clinician-Scientist of the Heart and Stroke Foundation. Rob’s clinical and academic interests include the access and outcomes of care for critically ill patients in the global context. He has investigated differential use of critical care resources according to gender, age, insurance status, and where people live in the world. His work has also highlighted how selective patient exclusion in clinical research leads to deceased generalizability of all our findings. In 2011 he studied differences in end-of-life care between Canada and the Unites States as a Commonwealth Fund Harkness Fellow. During the 2003 SARS epidemic, he helped to provide the first descriptions of critically ill patients and modes of disease transmission. Working with colleagues throughout North America, Asia, Europe and Australia during the 2009-10 Influenza Pandemic, he helped international research programs to study clinical characteristics, treatments and outcomes of patients with H1N1-related critical illness. In 2013-2014, working with the World Health Organization, he helped to establish a clinical research program for Middle East Respiratory Syndrome with colleagues in the Kingdom of Saudi Arabia. He is a clinical lead for the WHO in the West Africa Ebola virus disease outbreak.|
|Dr. Dale Gardiner||
Dr Gardiner is a UK Consultant in Adult Intensive Care Medicine. In June 2013 he became the UK Deputy National Clinical Lead for Organ Donation for NHS Blood and Transplant. Previously he was the local Clinical Lead for Organ Donation in Nottingham University Hospitals and the Regional Clinical Lead for Organ Donation in the Midlands. In February 2012 he joined the UK Donation Ethics Committee.
He is co-chair of the deceased donation working group for ELPAT (Ethical, Legal and Psychosocial Aspects of organ Transplantation as part of the European Society for Organ Transplantation) and deputy chair of the Nottingham University Hospital’s Ethics of Clinical Practice Committee. Dr. Gardiner was co‐leader for the Diagnosis of Death Masterclass in the NHS Blood and Transplant sponsored Professional Development Programme (2010), a part of a national initiative to provide professional development to clinical leads and non‐clinical donation committee chairpersons. His clinical forms for the diagnosis of death and pathways for best practice in organ donation are used extensively in the Midlands region and have been modified for national use. Together with colleagues from Nottingham University Hospitals he runs a multidisciplinary organ donation simulation course, which he has recently adapted and piloted as a new national course for intensive care trainees.
Dr Gardiner lectures and publishes on intensive care ethics, organ donation and the diagnosis of death. He recently published a Cochrane Diagnostic Test Accuracy Review into ‘CT angiography for confirmation of the clinical diagnosis of brain death’, is working with colleagues on a European collaboration to publish typical donation after circulatory death vignettes and is the UK lead for a proposed international observational trial on the physiology of dying.
|Dr. Laurance Lequier||
Dr. Laurance Lequier is a Pediatric Intensivist and Director of the Extracorporeal Life Support Program, at the Stollery Children’s Hospital in Edmonton, Alberta, Canada. His research interests include neurologic outcomes following extracorporeal membrane oxygenation (ECMO) and the anticoagulation of extracorporeal circuits. Dr. Lequier has been a steering committee member of the international Extracorporeal Life Support Organization (ELSO) for the past 5 years and is the chair of ELSO’s task force on ECMO Anticoagulation. Dr. Lequier is very involved with ECMO education and simulation and has spoken extensively on these topics throughout North and South America.
|Dr. Doug Brown||
Doug Brown is an Emergency physician at Royal Columbian Hospital, he is a BC mountain rescue technician, a member of the international commission for mountain emergency medicine as well as a ski doctor for Whistler Blackcomb and Mike Wiegele's helicopter skiing. He has a particular interest in wilderness and environmental emergencies, and was the lead author on a review of accidental hypothermia published in the November 15, 2012 issue of the New England Journal of Medicine.
|Dr. Hussein Kanji||Dr. Kanji is a clinician-scientist practicing in both the general systems ICU as well as the cardiac surgery ICU. He is dual board certified in Emergency medicine (UofA) and Critical Care Medicine at UBC. He has completed both Masters of Public Health and a Masters of Science. He is a fully trained echocardiographer and focuses a part of his research on ultrasound/echo-guided management of critically ill patients. His work in this field earned him the top research prize at the Society of Critical Care Medicine Congress as a fellow. His previous research includes work in ischemia reperfusion injury as a Master’s student, followed by developing a heart failure model and novel murine EKG monitoring device as a research fellow at MIT. Most recently, he has completed his ECMO specialization training at Glenfield Hospital (Leicester, UK) under the aegis of Mr. G. Peek (lead author of the CESAR trial). He is currently building an ECMO research program including the development of a prospective database, devising a prognostic score, PK/PD pharmacological studies and reporting on quality of life outcomes of patient on ECMO for ARDS.|
|Dr Noel Gibney||
Dr. Noel Gibney graduated from University College Dublin Medical School. He was registrar in Nephrology and Metabolic Medicine at St. Vincent’s University Hospital, Dublin, Ireland. He trained in Pulmonary Medicine at the University of Alberta, Edmonton, Alberta and in Critical Care Medicine at Massachusetts General Hospital, Boston, USA.
He was Zone Clinical Department Head for Critical Care for Alberta Health Services from 1995-2012 and Director of the Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta from 2002-2012. He practices as an intensivist in the the University of Alberta Hospital, Edmonton.
He is a Professor of Critical Care Medicine and Medicine. He has been awarded the Gold Humanism in Medicine Award at the University of Alberta and has been active in international disaster relief in Kosovo and Haiti.
Dr. Gibney’s research interests include the epidemiology and management of Acute Kidney Injury in the critically ill and Information Technology in the critical care unit. He has participated in the Acute Dialysis Quality Initiative (ADQI) and the Acute Kidney Injury Network (AKIN).
|Dr. Sonny Dhanani||
Dr. Dhanani is a pediatric intensivist at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa and Associate Professor (Pediatrics) at the University of Ottawa. He is the chief medical officer- donation for Trillium Gift of Life, Ontario’s organ procurement organization. He is also leading national research pertaining to practices and standards for determining death after cardiac arrest for the purposes of donation.
|Dr. Derek Angus||
Dr. Angus is Professor and Chair of the Department of Critical Care Medicine and Director of CRISMA (Clinical Research, Investigation, and Systems Modeling of Acute Illnesses) Center at the University of Pittsburgh. He holds secondary appointments in Medicine, Health Policy and Management, and Clinical and Translational Science. He trained at the University of Glasgow and University of Pittsburgh and spent a year in Hong Kong with Medicins Sans Frontieres.